A detailed history of Novare Capital Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Novare Capital Management LLC holds 1,299 shares of AMGN stock, worth $443,881. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,299
Previous 979 32.69%
Holding current value
$443,881
Previous $273,000 34.07%
% of portfolio
0.03%
Previous 0.02%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 03, 2025

BUY
$271.18 - $309.22 $86,777 - $98,950
320 Added 32.69%
1,299 $366,000
Q2 2025

Jul 29, 2025

BUY
$262.28 - $309.85 $78,683 - $92,955
300 Added 44.18%
979 $273,000
Q1 2025

Apr 29, 2025

BUY
$258.59 - $327.36 $175,582 - $222,277
679 New
679 $211,000
Q1 2024

May 06, 2024

BUY
$268.87 - $324.56 $236,336 - $285,288
879 New
879 $249,000
Q4 2021

Feb 03, 2022

SELL
$198.88 - $227.6 $269,084 - $307,942
-1,353 Closed
0 $0
Q3 2021

Nov 04, 2021

BUY
$212.27 - $248.7 $287,201 - $336,491
1,353 New
1,353 $288,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $183B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Novare Capital Management LLC Portfolio

Follow Novare Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Novare Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Novare Capital Management LLC with notifications on news.